Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.001 | 0.0855 | 0.0855 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.001 | 0.0855 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.001 | 0.0855 | 0.0855 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.001 | 0.0855 | 0.0855 |
Echinococcus granulosus | netrin receptor unc 5 | 0.0056 | 0.6413 | 0.6413 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.001 | 0.0855 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.001 | 0.0855 | 0.0855 |
Trypanosoma cruzi | ABC transporter, putative | 0.001 | 0.0785 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.001 | 0.0855 | 1 |
Wolbachia endosymbiont of Brugia malayi | ABC-type multidrug transport system, ATPase and permease component | 0.0003 | 0 | 0.5 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.001 | 0.0855 | 1 |
Schistosoma mansoni | ATP-binding cassette sub-family g2 (white protein) (abcg2) | 0.001 | 0.0785 | 0.0785 |
Trichomonas vaginalis | taga, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.001 | 0.0855 | 1 |
Toxoplasma gondii | ATP-binding cassette G family transporter ABCG84 | 0.001 | 0.0785 | 0.9181 |
Plasmodium falciparum | multidrug resistance protein 1 | 0.001 | 0.0855 | 1 |
Entamoeba histolytica | P-glycoprotein-5 | 0.001 | 0.0855 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.001 | 0.0855 | 0.0855 |
Entamoeba histolytica | P-glyco protein 6, putative | 0.001 | 0.0855 | 1 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0056 | 0.6413 | 1 |
Echinococcus granulosus | Ankyrin | 0.0056 | 0.6413 | 0.6413 |
Giardia lamblia | ABC transporter | 0.001 | 0.0758 | 1 |
Mycobacterium ulcerans | transmembrane ABC transporter ATP-binding protein | 0.001 | 0.0785 | 1 |
Echinococcus granulosus | ATP binding cassette sub family G | 0.001 | 0.0785 | 0.0785 |
Trichomonas vaginalis | abcb9, putative | 0.001 | 0.0855 | 1 |
Toxoplasma gondii | ATP-binding cassette transporter ABC.B1 | 0.001 | 0.0855 | 1 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.001 | 0.0855 | 1 |
Mycobacterium ulcerans | transmembrane ABC transporter ATP-binding protein | 0.001 | 0.0785 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0828 | 0.1291 |
Trypanosoma brucei | ABC transporter, putative | 0.001 | 0.0785 | 1 |
Echinococcus granulosus | ATP binding cassette sub family G | 0.001 | 0.0785 | 0.0785 |
Wolbachia endosymbiont of Brugia malayi | ABC-type protease secretion system, ATPase and permease component, AprD | 0.0003 | 0 | 0.5 |
Schistosoma mansoni | netrin receptor unc5 | 0.0056 | 0.6413 | 0.6413 |
Echinococcus granulosus | ATP binding cassette sub family G | 0.001 | 0.0785 | 0.0785 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.001 | 0.0855 | 1 |
Schistosoma mansoni | ABC transporter | 0.0008 | 0.0607 | 0.0607 |
Schistosoma mansoni | retinoblastoma-binding protein 4 (rbbp4) | 0.0056 | 0.6413 | 0.6413 |
Entamoeba histolytica | P-glycoprotein-2 | 0.001 | 0.0855 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0007 | 0.0479 | 0.0479 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.001 | 0.0855 | 0.0855 |
Trichomonas vaginalis | ABC transporter, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.001 | 0.0855 | 1 |
Plasmodium vivax | multidrug resistance protein 1, putative | 0.001 | 0.0855 | 1 |
Mycobacterium ulcerans | transmembrane ABC transporter ATP-binding protein | 0.001 | 0.0785 | 1 |
Trypanosoma brucei | ATP-binding cassette protein, putative | 0.001 | 0.0785 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.001 | 0.0855 | 0.0855 |
Plasmodium vivax | ABC transporter G family member 2, putative | 0.001 | 0.0785 | 0.9181 |
Echinococcus multilocularis | ATP binding cassette sub family G | 0.001 | 0.0785 | 0.0785 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.001 | 0.0855 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.001 | 0.0855 | 0.0855 |
Mycobacterium leprae | PROBABLE DRUGS-TRANSPORT TRANSMEMBRANE ATP-BINDING PROTEIN ABC TRANSPORTER | 0.0003 | 0 | 0.5 |
Schistosoma mansoni | ankyrin 23/unc44 | 0.0056 | 0.6413 | 0.6413 |
Entamoeba histolytica | P-glycoprotein-2, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.001 | 0.0855 | 1 |
Leishmania major | ATP-binding cassette protein subfamily G, member 4, putative | 0.001 | 0.0785 | 0.9181 |
Onchocerca volvulus | Netrin receptor homolog | 0.0056 | 0.6413 | 1 |
Brugia malayi | multidrug resistance protein 3 | 0.001 | 0.0855 | 0.1333 |
Schistosoma mansoni | multidrug resistance protein | 0.001 | 0.0855 | 0.0855 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.001 | 0.0855 | 1 |
Echinococcus granulosus | tumor necrosis factor receptor superfamily | 0.0086 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0056 | 0.6413 | 0.6413 |
Echinococcus multilocularis | tumor necrosis factor receptor superfamily | 0.0086 | 1 | 1 |
Mycobacterium tuberculosis | Probable conserved transmembrane ATP-binding protein ABC transporter | 0.0008 | 0.0579 | 0.6774 |
Entamoeba histolytica | P-glycoprotein-2 | 0.001 | 0.0855 | 1 |
Echinococcus granulosus | ankyrin repeat and death domain containing protein | 0.0056 | 0.6413 | 0.6413 |
Loa Loa (eye worm) | ABC transporter | 0.0008 | 0.0607 | 0.0946 |
Echinococcus granulosus | death domain containing protein | 0.0056 | 0.6413 | 0.6413 |
Leishmania major | ATP-binding cassette protein subfamily G, member 6, putative | 0.001 | 0.0785 | 0.9181 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.6413 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.001 | 0.0855 | 1 |
Entamoeba histolytica | P-glycoprotein-1 | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.001 | 0.0855 | 1 |
Leishmania major | p-glycoprotein | 0.001 | 0.0855 | 1 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.001 | 0.0855 | 0.1333 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.001 | 0.0855 | 1 |
Echinococcus multilocularis | TNFR CD27 30 40 95 cysteine rich region | 0.0086 | 1 | 1 |
Leishmania major | ATP-binding cassette protein subfamily B, member 2, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.001 | 0.0855 | 1 |
Trypanosoma cruzi | ATP-binding cassette protein, putative | 0.001 | 0.0785 | 1 |
Echinococcus multilocularis | Ankyrin | 0.0056 | 0.6413 | 0.6413 |
Plasmodium falciparum | ABC transporter G family member 2 | 0.001 | 0.0785 | 0.9181 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.001 | 0.0855 | 0.1333 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.6413 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.001 | 0.0855 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0056 | 0.6413 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.001 | 0.0855 | 0.0855 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0855 | 0.1333 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.001 | 0.0828 | 0.0828 |
Brugia malayi | ABC transporter family protein | 0.0008 | 0.0607 | 0.0946 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0007 | 0.0479 | 0.0479 |
Echinococcus multilocularis | netrin receptor unc 5 | 0.0056 | 0.6413 | 0.6413 |
Mycobacterium leprae | PROBABLE DRUGS-TRANSPORT TRANSMEMBRANE ATP-BINDING PROTEIN ABC TRANSPORTER | 0.0003 | 0 | 0.5 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.001 | 0.0828 | 0.0828 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0007 | 0.0479 | 0.5606 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0855 | 0.1333 |
Echinococcus multilocularis | ATP binding cassette sub family G | 0.001 | 0.0785 | 0.0785 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.001 | 0.0855 | 0.5 |
Echinococcus multilocularis | ATP binding cassette sub family G | 0.001 | 0.0785 | 0.0785 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.001 | 0.0855 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0056 | 0.6413 | 1 |
Echinococcus multilocularis | ankyrin repeat and death domain containing protein | 0.0056 | 0.6413 | 0.6413 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.001 | 0.0855 | 0.0855 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.001 | 0.0855 | 1 |
Schistosoma mansoni | tumor necrosis factor receptor related | 0.0086 | 1 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.001 | 0.0855 | 0.0855 |
Brugia malayi | Uncoordinated protein 44 | 0.0056 | 0.6413 | 1 |
Brugia malayi | Death domain containing protein | 0.0056 | 0.6413 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.001 | 0.0855 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.001 | 0.0855 | 0.0855 |
Entamoeba histolytica | ABC transporter, putative | 0.001 | 0.0785 | 0.9181 |
Brugia malayi | ABC transporter family protein | 0.001 | 0.0855 | 0.1333 |
Trichomonas vaginalis | ABC transporter, putative | 0.001 | 0.0855 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.001 | 0.0855 | 0.0855 |
Trichomonas vaginalis | ABC transporter, putative | 0.001 | 0.0855 | 1 |
Schistosoma mansoni | smdr2 | 0.001 | 0.0855 | 0.0855 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.001 | 0.0855 | 0.0855 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0007 | 0.0479 | 0.0479 |
Schistosoma mansoni | multidrug resistance protein | 0.001 | 0.0855 | 0.0855 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.001 | 0.0855 | 0.0855 |
Schistosoma mansoni | hypothetical protein | 0.0008 | 0.0579 | 0.0579 |
Entamoeba histolytica | P-glycoprotein 5, putative | 0.001 | 0.0855 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.001 | 0.0855 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.